The NIH predicts that number to keep growing into 2015 and beyond.
“The technologies that were used for the Human Genome Project are now distilled down to practical tools that clinicians can use to diagnose and, hopefully, treat diseases in patients that they couldn’t treat before,” said Leslie G. Biesecker, MD, of the National Human Genome Research Institute, in a news release.
“It’s come much faster and developed more quickly and become more useful clinically than I think any reasonable person would have suggested just 10 years ago. At that time, I don’t think anybody would have taken you seriously if you had said that in 2014, tens of thousands of patients would be getting clinical genome and exome sequencing.”
More Articles on Personalized Medicine:
12 Practical Criteria for Managing Population Health and Controlling Costs
Population Health Lessons From Hospitals in the U.S.’ Healthiest Counties: 3 CEOs Share Successes
10 Disruptive Forces in Healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.